8
H. Oukani et al. / Carbohydrate Research xxx (2013) xxx–xxx
20.8, 29.5 (Me acetate), 43.8 (MeN), 50.3, 53.3, 61.5, 61.6, 67.3,
67.8, 68.2, 68.8, 70.4, 70.6, 71.78, 73.1, 79.7, 127.6 (Ar), 127.7
(Ar), 128.2 (Ar). Anal. Calcd for C36H49NO18: C, 55.16; H, 6.30; N,
1.78. Found: C, 55.0; H, 6.2.
Ph), 4.60 (s, 2H, CH2Ph), 4.87 (s, 1H, H-1), 4.90 (d, 1H, CH2Ph), 5.00
(dd, 1H, J5,6 = 1.5; J6,7 = 6.5 Hz, H-6), 7.30–7.41 (m, 10H, 2Ph).
4.14. 1-C-[(3S,4R,5R)-4-[Methoxycarbonyl]-3-[(4S,5S)-5-
(phenylmethyloxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]-2-
(methyl)-5-isoxazolidinyl]-1,4-anhydro-1,2:4,5-bis-O-(1-
4.10. [N(Z)]-N-Oxide-N-[[(4R,5R)-2,2-dimethyl-5-
[(phenylmethoxy)methyl]-1,3-dioxolan-4-yl]methylene]-
methanamine (18)
methylethylidene)-(1R)-D-manno-pentitol (23)
Procedure B using 22 and 6, 72%, gum, ½a D25
ꢀ
24.1 (c 1.0, CHCl3);
;
The procedure used for the synthesis of 6 was used to provide
Rf 0.45 (cycloH/EA 3:2); IR (film), 1737 cmꢁ1 1H NMR (CDCl3,
18 as a syrup, ½a 2D5
ꢀ
ꢁ19.0 (c 0.9, CHCl3); Rf 0.13 (Ethylacetate);
400 MHz): d 1.33 (s, 3H, Me), 1.39 (s, 3H, Me), 1.40 (s, 3H, Me),
1.42 (s, 3H, Me), 1.43 (s, 3H, Me), 1.51 (s, 3H, Me), 2.93 (s, 3H,
1H NMR (CDCl3, 250 MHz): d 1.40 (s, 3H, Me), 1.45 (s, 3H, Me),
0
0
3.70 (s, 3H, NMe), 3.80 (dd, 1H, ; J1,1 = 10, J1,2 = 6 Hz, H-1), 3.90
NMe), 3.59 (dd, 1H, J1,2 = 6.3, J1,1 = 10.3 Hz, H-1), 3.71 (dd, 1H,
0
(dd, 1H, J1 2 = 2.5 Hz, H-10), 4.20 (m, 1H, H-2), 4.70 (s, 2H, CH2Ph),
J1 ,2 = 3.4 Hz, H-10), 3.73 (s, 3H, OMe), 3.76 (dd, J3,4 = 6.9,
0
5.10 (dd, 1H, J3,4 = 6, J2,3 = 7 Hz, H-3), 6.95 (d, 1H, H-4), 7.28 (m,
5H, Ph); 13C NMR (CDCl3 62.9 MHz): d 26.3 (Me acetal), 26.9 (Me
acetal), 52.8 (NMe), 71.3 (C-1), 72.9 (C-3), 73.8 (OCH2Ph), 79.6 C-
2), 110.9 (C quat acetal), 127.6 (Ar), 127.8 (Ar), 128.3 (Ar), 138.0
J4,5 = 3.9 Hz, H-4), 3.82 (dd, J2,3 = 7.2 Hz, H-3), 3.95 (dd, 1H,
0
J10,11 = 5.2, J11,11 = 8.7 Hz, H-11), 3.98 (ddd, 1H, J2,3 = 7.2 Hz, H-2),
4.00 (dd, 1H, H-5), 4.05 (m, 2H, H-9, H-110), 4.33 (m, 1H, H-10),
4.57 (d, 1H, J7,8 = 5.9 Hz, H-7), 4.59 (d, 1H, J = 12.4 Hz, OCH-2Ph),
4.64 (d, 1H, OCH-2Ph), 4.77 (dd, 1H, J8,9 = 3.8 Hz, H-8), 7.35 (m,
5H, Ar); 13C NMR (CDCl3 100 MHz): d 24.2 (Me acetal), 25.2 (Me
acetal), 25.5 (Me acetal), 26.6 (Me acetal), 27.1 (Me acetal), 27.2
Me acetal), 47.4 (NMe), 52.1 (OMe), 55.0 (C-5), 66.3 (C-11), 1.0
(C-1), 1.5 (C-4) 73.2 (C-10), 73.4 (OCH2Ph), 78.2 (C-3), 79.1 (C-8),
79.5 (C-2), 79.9 (C-9), 84.7 (C-7), 109.1 (C quat acetal), 109.9 (C
quat acetal), 113.2 (C quat acetal), 116.5 (C-6), 27.6 (Ar), 127.7
(Ar), 128.4 (Ar), 138.1 (Cipso), 169.8 (CO); MS (HR-ESI) calcd for
(C-4), 138.1 (C ipso); MS (HR-ESI) calcd for
C15H21NNaO4
[M+Na]+ 302.1363, found: 302.1374.
4.11. 1-C-[(4R,5R)-4-[Ethoxycarbonyl]-3-[phenyl]-2-(methyl)-5-
isoxazolidinyl]-1,2:4,5-bis-O-(1-methylethylidene)-(1S)-
D-
manno-pentitol (17)
Procedure A using 8 and 10, 45%, foam, ½a D25
ꢀ
13.2 (c 0.6, CHCl3);
Rf 0.56 (H/EA 3:2); 1H NMR (CDCl3, 400 MHz): d 0.80 (t, 3H, Et),
1.38 (s, 3H, Me), 1.40 (s, 3H, Me), 1.45 (s, 3H, Me), 1.46 (s, 3H,
Me), 2.50 (d, 1H, J6,OH = 7.5 Hz, OH), 2.61 (s, 3H, NMe), 3.56–
3.77(m, 3H, COOCH2, H-2), 3.90 (m, 1H, H-1), 3.92 (m, 1H, H-6),
4.06–4.12 (m, 3H, H-7, H-8, H-80), 4.25 (dd, 1H, J3,4 = 7.8,
J4,5 = 6.8 Hz, H-4), 4.46 (dd, 1H, J5,6 = 1.0 Hz, H-5), 5.01 (dd, 1H,
J2,3 = 6.5 Hz, H-3), 7.29–7.38 (m, 5H, Ar); 13C NMR (CDCl3
100 MHz): d 13.8 (CH3), 25.0 (Me, acetal), 25.7 (Me, acetal), 26.8
(Me, acetal), 27.1 (Me, acetal), 43.6 (NMe), 58.5 (C-2), 60.7 (CH2,
COOEt), 67.3 (C-8), 69.5 (C-6), 75.7 (C-5, C-1), 76.4 (C-7), 78.0 (C-
3), 78.3 (C-4), 109.0 (C quat acetal), 109.5 (C quat acetal), 128.3
(Ar), 128.5 (Ar), 135.7 (C ipso), 170.5 (CO); MS (HR-ESI) calcd for
C
30H44NO11 [M+H]+ 594.2909, found: 594.2931.
4.15. 1-C-[(3R,4R,5R)-4-[Methoxycarbonyl]-3-[(4S,5S)-5-
(phenylmethyloxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]-2-
(methyl)-5-isoxazolidinyl]-1,4-anhydro-1,2:4,5-bis-O-(1-
methylethylidene)-(1R)-D-manno-pentitol (24)
Procedure B using 22 and 6, 18%, gum, ½a D25
ꢀ
65.3 (c 0.3, CHCl3);
1H NMR (CDCl3,
Rf 0.33 (cycloH/EA 3:2); IR (film), 1736 cmꢁ1
;
400 MHz): d 1.36 (s, 3H, Me), 1.37 (s, 3H, Me), 1.39 (s, 3H, Me),
1.42 (s, 3H, Me), 1.44 (s, 3H, Me), 1.52 s, 3H, Me), 2.82 (br m, 1H,
H-4), 2.88 (s, 3H, NMe), 3.45 (m, 2H, H-1, H-10), 3.48 (s, 3H, Me),
3.90 (d, 1H, J4,5 = 7.0 Hz, H-5), 3.97–4.08 (m, 4H, H-2, H-9, H-11,
H-110), 4.26 (m, 1H, H-10), 4.53 (d, 1H, J = 12.3 Hz, OCH2Ph), 4.59
(d, 1H, J7,8 = 5.7 Hz, H-7), 4.60 (d, 1H, OCH2Ph), 4.67 (dd, 1H,
J2,3 = 6.2, J3,4 = 9.2 Hz, H-3), 4.84 (dd, 1H, J8,9 = 3.7 Hz, H-8), 7.33
(m, 5H, Ar); 13C NMR (CDCl3 100 MHz): d 24.6 (Me acetal), 25.4
(Me acetal), 26.8 (Me acetal), 26.9 (Me acetal), 27.6 (Me acetal),
27.9 Me acetal), 46.2 (NMe), 1.5 (OMe), 4.1 (C-5), 67.0 (C-11),
70.6 (C-1), 73.0 (C-10), 73.4 (C-, CH2Ph), 75.6 (C-3), 79.5 (C-8, C-
2), 80.1 (C-9), 84.8 (C-7), 109.3 (C quat acetal), 110.1 (C quat ace-
tal), 111.4 (C-6), 113.5 (C quat acetal), 127.6 (Ar), 128.4 (Ar),
137.9 (C ispo), 167.9 (CO); MS (HR-ESI) calcd for C30H44NO11
[M+H]+ 594.2909, found: 594.2924.
C
24H37NO8 [M+H]+ 466.2435, found: 466.2425.
4.12. 1-C-[(3R,4R,5R)-4-[Ethoxycarbonyl]-3-[(4R,5R)-5-
(phenylmethyloxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]-2-
(methyl)-5-isoxazolidinyl]-1,2:4,5-bis-O-(1-methylethylidene)-
(1S)-D-manno-pentitol (19)
Procedure A using 8 and 18, 51%, foam, ½a D25
ꢀ
19 (c 0.8, CHCl3); Rf
0.45 (H/EA 2:1); 1H NMR (CDCl3, 400 MHz): d 1.25 (t, 3H, Et), 1.30–
1.45 (6s, 18H, 6Me), 2.30 (1H, OH), 2.85 (s, 3H, NMe), 3.00 (dd, 1H,
0
J3,4 = 6, J4,5 = 2.5 Hz, H-4), 3.6 (dd, 1H, J1,2 = 6, J1,1 = 10 Hz, H-1), 3.7
(m, 2H, H-10, H-5); 3.85 (bd, 1H, J9,10 = 7 Hz, H-9); 4.0–4.1 (m, 5H,
H-3, H-6, H-10, H-11, H-110), 4.3 (m, 3H, COOCH2, H-2), 4.4 (dd,
1H, J7,8 = 6.5, J6,7 = 10 Hz, H-7); 4.5 (d, 1H, H-8), 4.7 (s, 2H, CH2Ph);
7.28 (m, 5H, Ph).
4.16. 1-C-[(3S,4R,5R)-4-[methoxycarbonyl]-3-[(4S,5S)-5-
(phenylmethyloxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]-2-
(phenylmethyl)-5-isoxazolidinyl]-1,4-anhydro-1,2:4,5-bis-O-(1-
4.13. 1-C-[(3R,4S,5S)-4-[Methoxycarbonyl]-3-[(4S,5S)-5-
(phenylmethyloxymethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]-2-
(methyl)-5-isoxazolidinyl]-5-(methyl 2,3-O-isopropylidene-4-
methylethylidene)-(1R)-D-manno-pentitol (25)
Procedure B using 22 and 7, 83%, gum, ½a D25
ꢀ
+27.9 (c 0.9, CHCl3);
O-phenylmethylene-(5S)-
a-
D-lyxopyranoside) (21)
1H NMR (CDCl3, 400 MHz): d 1.30 (s, 3H, Me), 1.33 (s, 3H, Me), 1.39
(s, 3H, Me), 1.41 (s, 3H, Me), 1.45 (s, 3H, Me), 1.53 (s, 3H, Me), 3.52
Procedure A using 20 and 6, 13%, gum, ½a D25
ꢀ
17.5 (c 0.7, CHCl3);
(dd, 1H, J1,1 = 10, J1,2 = 6.5 Hz, H-1), 3.64 (ddd, 1H, J1 ,2 = 2.5,
J2,3 = 7.0 Hz, H-2), 3.70 (dd, 1H, H-10), 3.71 (dd, 1H, J3,4 = 8.5 Hz,
H-3), 3.80 (s, 3H, OMe), 4.00 (dd, 1H, J4,5 = 2.5 Hz, H-4), 4.02 (m,
1H, H-11), 4.05 (m, 1H, H-9), 4.08 (m, 1H, H-110), 4.09 (d, 1H, H-
5), 4.28 (d, 1H, J = 12 Hz, NCH2Ph), 4.37 (m,1H, H-10), 4.40 (d,
1H, NCH2Ph), 4.54 (d, J = 12.2 Hz, OCH2Ph), 4.55 (d, 1H,
J7,8 = 6.0 Hz, H-7), 4.61 (d,1H, OCH-2Ph), 4.73 (dd, 1H, J7,8 = 6.0,
0
0
Rf 0.38 (H/EA); 1H NMR (CDCl3, 400 MHz): d 1.25–1.45 (4s, 12H,
4Me), 2.75 (s, 3H, NMe), 3.12 (dd, 1H, J4,5 = 8, J3,4 = 7 Hz, H-4),
3.22 (s, 3H, OMe), 3.50 (dd, 1H, J7,8 = 2, J8,9 = 7.5 Hz, H-8), 3.56
(m, 2H, H-11, H-110), 3.65 (s, 3H, COOMe), 3.72 (m, 1H, H-10),
3.8 (dd, 1H, J9,10 = 5 Hz, H-9), 3.85 (m, 2H, H-5, H-7), 4.10 (d, 1H,
J2,3 = 5.5 Hz, H-2), 4.24 (dd, 1H, H-3), 4.44 (d, 1H, Jgem = 11 Hz CH2-